loader2
Partner With Us NRI

Aarey Drugs & Pharmaceuticals Ltd share Price Today

Company details

48.50
49.00
28.20
68.00
6M Return 3.27%
1Y Return 70.14%
Mkt Cap.(Cr) 137.46
Volume 34,231
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 34,231

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Aarey Drugs & Pharmaceuticals Ltd shares SWOT Analysis

Strengths (6)

  • Rising Net Cash Flow and Cash from Operating activity
  • Company with Low Debt
  • Increasing profits every quarter for the past 3 quarters

Weakness (7)

  • Promoter holding decreased by more than -2% QoQ
  • Negative profit growth, promoters decreasing shareholding QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Opportunity (0)

Data not found

Threats (3)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)
  • RSI indicating price weakness

Resistance and support

R1 49.2
R2 49.3
R3 49.7
Pivot

48.83

S1 48.7
S2 48.3
S3 48.2
EMA SMA
50.3
49.6
48.8
46.7
51.1
48.5
50.0
48.5
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MITTAL RIMPY Bulk Purchase 2022-10-13 41.38 162073 NSE
MITTAL RIMPY Bulk Sell 2022-10-13 41.44 137573 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2022-01-05 56.16 127421 NSE
Name Category Shares
Bina Rajesh Ghatalia PROMOTER 14.27%
Mihir Rajesh Ghatalia PROMOTER 10.11%
Nimit Rajesh Ghatalia PROMOTER 4.1%
Mira Mihir Ghatalia PROMOTER 2.46%
Nimit Impex PROMOTER 7.16%
Suraj Tradelinks PROMOTER 7.16%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Aarey Drugs & Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Aarey Drugs & Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 49.00 1,476.00 1,495.05 4,444.05 1,042.50
% Change -0.51 -0.20 0.10 -0.09 -0.22
Mcap Cr 137.46 354,141.85 120,705.40 117,975.75 104,899.89
Revenue TTM Cr 418.96 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 3.77 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 30.08 35.44 28.31 73.81 27.28
1 Year Return 70.14 52.41 56.35 27.78 103.59
ROCE 6.28 16.79 14.76 19.30 16.25
ROE 3.26 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 115.09 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 38,211.58 -20,152.87
LAST 3M 113,440.41 -31,179.37
LAST 6M 172,266.38 32,742.67
LAST 12M 272,035.18 123,918.17
Board Meeting for Today

May 30, 2024 l Board Meetings for Today

NSE Board Meetings Forthcomming

May 30, 2024 l NSE Board Meetings Forthcomming

Aarey Drugs & Pharmaceuticals to hold board meeting

May 28, 2024 l BSE Announcement

Date Action Type Ratio
No data found

Aarey Drugs & Pharmaceuticals Ltd Information

Stock PE (TTM)
30.08
Promoter Holding
45.28%
Book Value
46.8484
ROCE
6.28%
ROE
3.26%
Description
  • Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API`s Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane. The company`s products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office is located at Mumbai. The company was established with the main object setting up manufacturing facilities for Bulk Drugs. In the year 1993, the company came with a public issue of 27,50,000 equity shares of Rs 10 each for cash at par aggregating to Rs 275 lakh. Also, the company shares were listed on the BSE, ASE & DSE. In May 2009, the company plant started to upgrade the existing plant into international standards. In June 2016, the Company commenced manufacturing of Mono Methyl Urea & Di Methyl Urea. In 2017-18, it added new products i.e. Erithromycin Derivates & Mafenamic Acid with capacity of 10 m.t. & 25 m.t. respectively in June` 2017. In 2018-19, it commenced manufacturing of products i.e. Ortho Para Nitro Anisole, 2-Bromomethyl-1,3 dioxolane, and Mefenamic Acid. It also commenced manufacturing products i.e.Metformin & Urasil.

Registered Address

E-34 MIDC Tarapur, Boisar, Thane, Maharashtra, 401506

Tel : 91-22-23455543
Email : investorgrievance:aareydrugs.com
Website : http://www.aareydrugs.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524412
NSE Code : AAREYDRUGS
Book Closure Date (Month) : Aug/Sep
BSE Group : T
ISIN : INE198H01019

FAQ’s on Aarey Drugs & Pharmaceuticals Ltd Shares

You can buy Aarey Drugs & Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarey Drugs & Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 29, 2024 03:40 PM the closing price of Aarey Drugs & Pharmaceuticals Ltd was Rs.49.00.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 29, 2024 03:40 PM, the market cap of Aarey Drugs & Pharmaceuticals Ltd stood at Rs. 137.46.

The latest PE ratio of Aarey Drugs & Pharmaceuticals Ltd as of May 29, 2024 03:40 PM is 30.08

The latest PB ratio of Aarey Drugs & Pharmaceuticals Ltd as of May 29, 2024 03:40 PM is 0.96

The 52-week high of Aarey Drugs & Pharmaceuticals Ltd share price is Rs. 68.00 while the 52-week low is Rs. 28.20

Download App

Download Our App

Play Store App Store
market app